FI46844C - Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi. - Google Patents

Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi.

Info

Publication number
FI46844C
FI46844C FI701704A FI170470A FI46844C FI 46844 C FI46844 C FI 46844C FI 701704 A FI701704 A FI 701704A FI 170470 A FI170470 A FI 170470A FI 46844 C FI46844 C FI 46844C
Authority
FI
Finland
Prior art keywords
trichlorosteroids
9alpha
preparation
Prior art date
Application number
FI701704A
Other languages
English (en)
Swedish (sv)
Other versions
FI46844B (fi
Inventor
Laurent
Kolb
Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of FI46844B publication Critical patent/FI46844B/fi
Publication of FI46844C publication Critical patent/FI46844C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
FI701704A 1969-07-24 1970-06-16 Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi. FI46844C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1938218A DE1938218C3 (de) 1969-07-24 1969-07-24 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FI46844B FI46844B (fi) 1973-04-02
FI46844C true FI46844C (fi) 1973-07-10

Family

ID=5741103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI701704A FI46844C (fi) 1969-07-24 1970-06-16 Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi.

Country Status (18)

Country Link
US (1) US3681405A (fi)
JP (1) JPS4815290B1 (fi)
AT (1) AT300217B (fi)
BE (1) BE753874A (fi)
CH (1) CH557339A (fi)
CS (1) CS161757B2 (fi)
DE (1) DE1938218C3 (fi)
DK (1) DK122454B (fi)
ES (1) ES381790A1 (fi)
FI (1) FI46844C (fi)
FR (1) FR2059554B1 (fi)
GB (1) GB1317194A (fi)
IE (1) IE34401B1 (fi)
IL (1) IL34976A (fi)
NL (1) NL7010876A (fi)
PL (1) PL79781B1 (fi)
SE (1) SE355578B (fi)
ZA (1) ZA704574B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2725008C (en) 2008-05-28 2017-09-05 Validus Biopharma, Inc. Non-hormonal steroid modulators of nf-.kappa.b for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
US3025312A (en) * 1959-07-14 1962-03-13 Olin Mathieson 9alpha, 11beta-dichloro pregnanes
US3038898A (en) * 1960-11-10 1962-06-12 Syntex Sa 6-fluoromethyl-9alpha, 11beta-dichlorocortical hormones

Also Published As

Publication number Publication date
GB1317194A (en) 1973-05-16
US3681405A (en) 1972-08-01
CH557339A (de) 1974-12-31
AT300217B (de) 1972-07-25
CS161757B2 (fi) 1975-06-10
BE753874A (fr) 1971-01-25
DE1938218C3 (de) 1978-10-19
IL34976A0 (en) 1970-09-17
SE355578B (fi) 1973-04-30
DE1938218B2 (de) 1978-01-26
FR2059554B1 (fi) 1974-06-14
DK122454B (da) 1972-03-06
FR2059554A1 (fi) 1971-06-04
IL34976A (en) 1973-06-29
IE34401L (en) 1971-01-24
DE1938218A1 (de) 1971-02-04
FI46844B (fi) 1973-04-02
ES381790A1 (es) 1972-12-01
IE34401B1 (en) 1975-04-30
PL79781B1 (fi) 1975-06-30
ZA704574B (en) 1971-03-31
NL7010876A (fi) 1971-01-26
JPS4815290B1 (fi) 1973-05-14

Similar Documents

Publication Publication Date Title
IT1043829B (it) Procedimento per la preparazione di 6,7 benzohorfani
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
FI49716C (fi) Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi.
FI46166C (fi) Menetelmä teknisesti käyttökelpoisten 2,4,6,8,9-penta-atsa-bisyklo-/3. 3.1/-nona-2,6-dieenien valmistamiseksi.
FI51700C (fi) Menetelmä rauhoittavina lääkeaineina käyttökelpoisten 6-fenyyli-4H-s-t riatsolo-(1,5a)(1,4)-bentsodiatsepiinien valmistamiseksi.
FI49517C (fi) Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi.
FI46374C (fi) Menetelmä 2'-substituoitujen steroidi-(17alfa,16alfa-d)-oksatsoliinien valmistamiseksi.
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
NO740841L (no) Fremgangsmåte for fremstilling av 1-beta-D-ribofuranosyl-1, 2, 4-triazol-3-karboksamid.
FI46844C (fi) Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi.
FI49161C (fi) Menetelmä kardenolidi-3-(2´,3´-didesoksi-2´,3´-oksido-glykosidien) val mistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI51183C (fi) Menetelmä 2-hydroksimetyyli-3-karbonihappoamido-kinoksaliini-di-N-oksi de-(1,4)-yhdisteiden valmistamiseksi.
FI51496C (fi) Menetelmä vanadiinikarbidin valmistamiseksi.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
FI46724C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
FI52088C (fi) Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi.
FI51699C (fi) Menetelmä 6-fenyyli-4H-s-triatsolo-(4,3a)(1,4)-bentsodiatsepiinijohdan naisten valmistamiseksi.
FI45657C (fi) Menetelmä 6 alfa, 9alfa-difluoriprednisolonin 17,21-diestereiden valmi stamiseksi.
IL35278A0 (en) Process for the preparation of 4,5,6,7-tetrahydrocyclopenta-1,3-dioxinones-(4)
FI45755C (fi) Menetelmä 1,2-epoksi-9beta,10alfa-steroidien valmistamiseksi.
FI47885C (fi) Menetelmä 1,2 alfa-metyleeni-6,7 alfa-difluorimetyleeni-20-spiroks-4-e eni-3-onin valmistamiseksi
FI47351C (fi) Menetelmä 7alfa-metyyli-1alfa,2alfa-metyleeni-androstenolonien valmist amiseksi.